This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: The Innovative Contributions of Hans-Hermann Lau
Introduction
Hans-Hermann Lau is a notable inventor based in Bad Soden, Germany. He has made significant contributions to the field of chemistry, particularly in the development of processes for crystallizing complex compounds. His work is characterized by a focus on purity and efficiency in chemical processes.
Latest Patents
One of Hans-Hermann Lau's key patents is titled "Process for crystallizing N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide." This invention relates to a method for obtaining N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide in crystalline form, which is essentially free of byproducts. The process involves transferring the compound into an organic solvent or mixtures of organic solvents and water. The amount of byproduct in the solution is determined through quantitative analysis, and an equimolar amount of a base is added. The desired compound is then isolated from the resulting solution by crystallization.
Career Highlights
Hans-Hermann Lau is associated with Aventis Pharma Deutschland GmbH, where he has contributed to various innovative projects. His expertise in crystallization processes has been instrumental in advancing pharmaceutical formulations. Lau's work has not only enhanced the efficiency of chemical processes but has also ensured the high quality of pharmaceutical products.
Collaborations
Throughout his career, Hans-Hermann Lau has collaborated with esteemed colleagues such as Udo Hedtmann and Andreas Gappisch. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Hans-Hermann Lau's contributions to the field of chemistry, particularly through his innovative patent, highlight his commitment to advancing pharmaceutical processes. His work continues to influence the industry, ensuring the development of high-quality products.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
